New study aims to uncover hidden kidney risks in cystic fibrosis patients

NCT ID NCT06595420

Recruiting now Knowledge-focused Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why people with cystic fibrosis often develop kidney disease. Researchers will test blood and urine samples for early signs of kidney damage, comparing CF patients with and without frequent hospital stays, as well as people without CF. The goal is to find better ways to predict, detect, and prevent kidney problems in this population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to detect and prevent kidney damage in people with cystic fibrosis.
What could go wrong: This is an observational study, not a treatment trial. It may not directly change care, and results may not apply to all CF patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury chronic kidney disease chronic renal failure syndrome cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE KIDNEY INJURY CHRONIC KIDNEY DISEASE (CKD) CYSTIC FIBROSIS (CF)

Contacts and locations

Locations

Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth
RECRUITING

Lebanon, New Hampshire, 03756, United States
University of Alabama at Birmingham
RECRUITING

Birmingham, Alabama, 35233, United States
University of Virginia Children's Hospital
RECRUITING

Charlottesville, Virginia, 22908, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.